Pharvaris N.V. financial data

Symbol
PHVS on Nasdaq
Location
Leiden
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 07 Apr 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 54,379,491 shares 4%

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense €23,067,934 EUR 57%
General And Administrative Expense €11,314,067 EUR 46%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets €291,374,765 EUR -27%
Liabilities €23,614,024 EUR 61%